Two methods for measuring cross-reactivity could boost the safety of T-cell therapies.
References
Sewell, A.K. Nat. Rev. Immunol. 12, 669–677 (2012).
Birnbaum, M.E. et al. Cell 157, 1073–1087 (2014).
Zhang, S. et al. Nat. Biotechnol. 36, 1156–1159 (2018).
Bentzen, A.K. et al. Nat. Biotechnol. 36, 1191–1196 (2018).
Altman, J.D. et al. Science 274, 94–96 (1996).
Newell, E.W. et al. Nat. Biotechnol. 31, 623–629 (2013).
Huang, J. et al. Proc. Natl. Acad. Sci. USA 113, E1890–E1897 (2016).
Dolton, G. et al. Front. Immunol. 9, 1378 (2018).
Bentzen, A.K. et al. Nat. Biotechnol. 34, 1037–1045 (2016).
Rodenko, B. et al. Nat. Protoc. 1, 1120–1132 (2006).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Natarajan, A., Krogsgaard, M. The myriad targets of a T cell. Nat Biotechnol 36, 1152–1154 (2018). https://doi.org/10.1038/nbt.4309
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.4309
- Springer Nature America, Inc.